4th Quarter - Report

MONUMENT ADVOCACY for NOVARTIS

A later version of this report replaces this one, so LegiList's totals use the current version instead. This page shows this version exactly as filed.

Firm
Client
Income
$30,000
Expenses
—

Versions of this report

Every filing the register holds for this firm, client and period, oldest first. The most recent one is the version LegiList counts.

Filing Filed Amount Counted
4th Quarter - Report (this page) Jan 19, 2016 $30,000 Replaced
4th Quarter - Amendment Jan 6, 2017 $20,000 Yes

What was lobbied

3 issue areas, each in the filer's own words, with who lobbied on it and where.

Trade (domestic/foreign) TRD

Issues related to Trans-Pacific Partnership; general market access issues and intellectual property.

Foreign entity interest: Novartis is owned by Novartis, AG based in Basel, Switzerland.

Contacted: HOUSE OF REPRESENTATIVES; SENATE

Health Issues HCR

Issues related to domestic healthcare including biosimilars and orphan drugs

Foreign entity interest: Novartis is owned by Novartis AG based in Basel, Switzerland.

Contacted: SENATE; HOUSE OF REPRESENTATIVES

Taxation/Internal Revenue Code TAX

Issues related to corporate tax reform; tax extenders; H.R. 22, Fixing America's Surface Transportation (FAST) Act; orphan drugs

Foreign entity interest: Novartis is owned by Novartis AG based in Basel, Switzerland.

Contacted: SENATE; HOUSE OF REPRESENTATIVES

Bills named: H.R. 22 (114th)

Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.